Pharmaceutical Industry news, analysis and insights
US biotech firm Moderna has chosen Harwell Science Campus in Oxfordshire for its new UK R&D facility. The campus is already home to more than 70 organisations and sits within the UK’s ‘golden triangle’, an area rich in life sciences facilities, between Oxford, Cambridge and London.
REGENXBIO, a clinical-stage biotech company, has announced positive phase 2 data for its drug rxg-314, which was developed by the company’s NAVXpress bioreactor platform process.
J&J has begun scaling back its COVID-19 vaccine producation due to the falling demand for the jabs
Eli Lilly has announced plans to invest $450m in manufacturing facilities at Research Triangle Park in North Carolina, US
Daiichi Sankyo shares plans to build its first mRNA COVID-19 vaccine factory in Japan